CCC-TRIO 2025: Two days of exchange, networking and translational collaboration in cancer research
More than 450 participants, 135 posters, 2 CCC Lifetime Achievement Awards and top keynotes and plenty of exchange: for two days, translational cancer research was the focus of the CCC-TRIO Symposium 2025 of the Comprehensive Cancer Center Vienna of MedUni Vienna and Vienna General Hospital. Over 450 participants came together at MedUni Vienna's Lecture Center on 12 and 13 June to discuss the latest scientific developments, present young researchers and initiate new collaborations.
Das war CCC TRIO 2025 ©CCC Vienna/Oliver Knappl
The topics covered ranged from immuno-oncology and cancer epidemiology, artificial intelligence and machine learning to new therapeutic targets and biomarkers. The keynotes by renowned scientists Florian Greten, Douglas Hanahan, Catherine Alix-Panabières, Tjalling Bosse, Anna Fagotti, Freddie Bray, Péter Hegyi and Thomas Powles provided visionary impetus - both in terms of scientific concepts and clinical applications. At the same time, the symposium - with the participation of the Medical Universities of Graz and Innsbruck - offered plenty of space for young cancer researchers, personal encounters and interdisciplinary cooperation. "We need formats like CCC-TRIO to learn from each other - basic research from the clinic, and vice versa. This is the only way to create real translation," says CCC Director Shahrokh F. Shariat.
Awards, Awards, Awards beim CCC TRIO 2025 © CCC Vienna/Oliver Knappl
Poster Prizes 2025 - awards for excellent young researchers
A key highlight was the moderated poster session on June 12. June, in which 135 young cancer researchers presented their work. The best posters were judged in two categories, here are the winners:
Basic Translational Poster Awards
- 1. Place (EUR 2.000): Jonatan Kendler – CDK6 and STAT5B are vital for oncogenic transformation in ALCL
- 1. Place (EUR 2.000): Lena Hauser – Characterization of the heterogeneity of Antibody Drug Conjugate targets in bladder cancer on single cell level
- 2. Place (EUR 1.000): Bernadette Blauensteiner – Axl Shapes the Tumor Microenvironment in Colorectal Cancer
- 2. Place (EUR 1.000): Michael Gutmann – Albumin-targeted oxaliplatin(IV) prodrugs bearing the TLR-7 agonist gardiquimod for enhanced immunochemotherapy
- 3. Place (EUR 500): Lisa Mayr – Combination of CDK4/6 and MEK inhibition increases antitumor effects in pediatric high-grade glioma harboring concomitant BRAF mutation and CDKN2A/B loss
- 3. Place (EUR 500): Monika Homolya – A20: a checkpoint regulator in KRAS-driven lung adenocarcinoma
Clinical Translational Poster Awards
- 1. Place (EUR 2.000): Stephan Brönimann – Comprehensive analysis of microRNA expression provides mechanistic insights into transcriptomic alteration in primary and metastatic testicular germ cell tumors
- 2. Place (EUR 1.000): Zsófia Doboly – Integrative single-cell profiling uncovers metabolic and immune signatures in the triple-negative breast cancer microenvironment
- 3. Place (EUR 500): Heidemarie Ofner – Cytoreductive Radical Prostatectomy in oligometastatic Prostate Cancer Patients with perioperative systemic Therapy
- 3. Place (EUR 500): Lilla Horvath – Rapid research autopsy of SCLC patients: Insights into tumor heterogeneity
Workshops, poster walks & panels: space for exchange
Three interactive workshops of the Young CCC Board offered practical input on biobanks, organoids and patients as a link between research and industry. In addition, experts from science, politics and public health discussed the future of cancer strategy in Austria - with a clear goal: better translation, stronger networking, faster implementation.
Lifetime Achievement Awards for HPV research
A festive highlight was the presentation of the CCC Lifetime Achievement Awards 2025. Professor Reinhard Kirnbauer (Department of Dermatology, emeritus) and Professor Elmar Joura (Department of Obstetrics and Gynecology) were honored for their pioneering contributions to translational cancer research - in particular for the development and global implementation of the HPV vaccine, which has prevented hundreds of thousands of cancer cases worldwide. “With Reinhard Kirnbauer and Elmar Joura, we are honoring two scientists and physicians who have conducted excellent translational research for the benefit of mankind and have thus written medical history,” explains Shahrokh Shariat, Head of the CCC Vienna. "Thanks to their work, it is now possible to prevent six different types of cancer with a vaccine - including cervical, vulvar, anal and penile cancers as well as throat cancer. This is a milestone in cancer medicine."
Venue:
CCC-TRIO 2025 - Translational Research in Oncology
June 12-13, 2025 | Lecture Hall Center, MedUni Vienna / Vienna General Hospital
Währinger Gürtel 18-20, 1090 Vienna | Level 8, Lecture Hall 1
Scientific Committee:
Walter Berger, Nicole Concin, Stephan Polterauer, Shahrokh F. Shariat, Maria Sibilia and the Board of the Young CCC Vienna
Further information, program and review at:
https://ccc.meduniwien.ac.at/forschung/ccc-trio-symposium/
CCC-TRIO 2025 - Join the Future of Oncology.